Tandem inks distro deal in Italy for insulin pump

Tandem Diabetes Care (NSDQ:TNDM) has signed a distribution deal with Movi SpA to commercialize Tandem’s t:slim X2 insulin pump in Italy.

The San Diego, Calif.-based company said today that Movi is slated to run sales, marketing and customer training for Tandem’s products in Italy, according to the terms of the agreement.

Get the full story at our sister site, Drug Delivery Business News.

The post Tandem inks distro deal in Italy for insulin pump appeared first on MassDevice.

from MassDevice https://ift.tt/2qjKli9